What is Microbiosensor?
Microbiosensor Ltd. is at the forefront of developing advanced point-of-care diagnostic devices. Leveraging proprietary chemical reagents, their MicroBioSensors offer a rapid color-change detection method for bacterial infections. These systems serve as crucial early warning indicators for microbial infections, enabling healthcare providers to swiftly assess leukocyte levels and antibiotic sensitivities. The technology is engineered to augment existing laboratory workflows, thereby enhancing patient care and actively combating the growing threat of antimicrobial resistance. Their innovative solutions are particularly valuable for professionals in peritoneal dialysis and other medical fields requiring swift and dependable diagnostic tools.
How much funding has Microbiosensor raised?
Microbiosensor has raised a total of $920K across 1 funding round:
Private Equity
$920K
Private Equity (2017): $920K with participation from Northern Powerhouse Investment Fund
Key Investors in Microbiosensor
Northern Powerhouse Investment Fund
The Northern Powerhouse Investment Fund is dedicated to boosting the regional economy through strategic investments in skills, innovation, transport, and culture, aligning with Microbiosensor's mission to advance healthcare technology.
What's next for Microbiosensor?
The recent major strategic investment positions Microbiosensor for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, scale manufacturing capabilities, and expand its commercial reach. The company's focus on addressing critical needs in infection detection and antimicrobial resistance suggests a strategic roadmap aimed at solidifying its position as a key player in the diagnostics industry. Future developments will likely involve broader clinical adoption and potential expansion into new diagnostic areas.
See full Microbiosensor company page
